Side effects are an important part of the conversation before any prescription weight-management treatment is started. Not everyone experiences them, and the type and severity depend on the medicine and the individual. A proper clinical assessment and ongoing review help ensure that treatment remains appropriate.
This guide explains general principles rather than promoting a particular prescription medicine. Your prescriber and the patient information leaflet supplied with your medicine are the appropriate sources for advice specific to your treatment.
Explore Longeva Wellness Weight Management in Rochdale
What Side Effects Can Occur During Medical Weight Management?
Different prescription weight-management medicines have different side-effect profiles. With medicines that act on GLP-1 pathways, gastrointestinal symptoms are among the most commonly reported effects. These can include nausea, vomiting, diarrhoea, constipation and abdominal discomfort.
Symptoms may be more noticeable when treatment is started or adjusted. They should not simply be ignored if they are severe, persistent or affecting your ability to eat or drink normally.
Nausea, Vomiting and Diarrhoea
Nausea, vomiting and diarrhoea can occur with some weight-management medicines. Although these effects are often mild to moderate or short-lived, persistent vomiting or diarrhoea can cause dehydration and may require medical assessment.
Contact your healthcare professional if symptoms are troublesome, persistent or worsening. Seek more urgent advice if you cannot keep fluids down, feel significantly unwell or have signs of dehydration.
Constipation and Digestive Changes
Constipation can also occur. Changes in appetite and food intake may alter bowel habits, but persistent or severe abdominal symptoms should be discussed with a healthcare professional rather than assumed to be a normal part of treatment.
Do not add medicines or supplements to manage side effects without checking that they are suitable for you, particularly if you have other health conditions or take other medicines.
A Serious Warning Sign: Persistent Severe Abdominal Pain
Inflammation of the pancreas (acute pancreatitis) is an infrequent but potentially serious adverse effect reported with GLP-1 and dual GLP-1/GIP medicines. UK safety guidance was strengthened in January 2026 following rare reports of severe forms of pancreatitis.
Seek urgent medical attention if you develop severe, persistent abdominal pain, particularly pain that may radiate to the back and may occur with nausea or vomiting. Do not wait for a routine weight-management review.
What About Changes to Vision?
Some prescription medicines have specific warnings that require prompt assessment. For example, UK guidance advises people taking semaglutide to seek urgent medical advice for sudden loss of vision or rapid deterioration in eyesight. The risks relevant to you depend on the medicine you have actually been prescribed.
Pregnancy, Breastfeeding and Contraception
GLP-1 medicines should not be used during pregnancy, while trying to become pregnant or while breastfeeding. If you think you may be pregnant while using one, contact a healthcare professional promptly.
There are also medicine-specific contraception considerations. Current MHRA guidance states that people using tirzepatide who rely on an oral contraceptive should add a barrier method or switch to a non-oral method for four weeks after starting treatment and for four weeks after each dose increase. Your prescriber should discuss the advice relevant to your circumstances.
Do Not Change Your Dose Yourself
If side effects occur, do not increase, reduce, switch or stop prescription treatment without appropriate clinical advice unless you have been instructed to do so or require emergency care. The correct response depends on the medicine, symptoms and your medical history.
Regular reviews provide an opportunity to discuss tolerability and whether treatment remains suitable. Read our guide: How Often Should You Have Weight Management Reviews?
When Should You Contact the Weight Management Team?
Contact your healthcare professional if side effects are persistent, worsening, worrying or interfering with normal eating, drinking or daily activities. You should also tell them about new medical diagnoses, new medicines, pregnancy or other significant changes in your health.
For severe or rapidly worsening symptoms, seek urgent NHS medical help rather than waiting for a scheduled review.
Safe Weight Management Starts With Assessment
Prescription treatment is not suitable for everyone. Eligibility and treatment choice should be based on an individual assessment that considers BMI, health conditions, current medicines, contraindications and other relevant risk factors.
Read our guide to BMI and weight-management eligibility and what happens at a weight management consultation.
Weight Management Support in Rochdale and Greater Manchester
Longeva Wellness provides private weight-management consultations from Unit 1, Chichester Court, Milnrow Road, Rochdale, OL16 1UG. We support patients from Rochdale and surrounding areas including Milnrow, Littleborough, Heywood, Middleton, Oldham, Bury and elsewhere across Greater Manchester.
Book a private weight management consultation
Frequently Asked Questions
Does everyone get side effects?
No. Side effects vary between medicines and between individuals. Your prescriber should discuss the benefits and risks relevant to the treatment being considered for you.
Should I stop treatment if I feel sick?
Do not make treatment changes on the basis of generic online advice. Contact your prescriber or pharmacist for advice specific to your symptoms and medicine. Seek urgent medical care for serious symptoms.
When is abdominal pain an emergency?
Severe, persistent abdominal pain that may radiate to the back, particularly with nausea or vomiting, requires urgent medical attention because it can be a symptom of acute pancreatitis.
Clinical note: This article is general educational information and is not a substitute for individual medical advice. Prescription-only treatment is subject to clinical assessment, eligibility and prescriber approval.
0 comments